We are delighted to announce a Seventh Call to Application. We are looking to fund further projects that will help find a cure and/or a treatment for any of the three types of myotubular myopathy (congenital X-linked recessive; congenital autosomal recessive; autosomal dominant), focusing on research that would not generally be funded by public or industrial funding sources. Our Seventh Call will be open to research bodies internationally.
To date, we have awarded eleven research grants / fellowships for the following projects:
- Gene therapy for x-linked myotubular myopathy and pathophysiology – Dr Anna Buj Bello, Genethon, Evry – £102,290 over 2 years
- Membrane trafficking and T tubule structure and function in a canine model of centronuclear myopathies – Dr Richard Piercy, Royal Veterinary College, London – £38,548 over 3 years
- Deciphering the molecular pathway involving centronuclear myopathy genes – Manuela D’Alessandro, IGBMC, Illkirch – £120,000 over 3 years
- Gene therapy for autosomal dominant centronuclear myopathy by Transplicing – Dr Marc Bitoun, INSERM, Paris – £102,340 over 2 years
- Next generation sequencing to tackle centronuclear myopathies – Dr Jocelyn Laporte, IGBMC, France – £62,000 generic cialis for sale over 2 years
- Secondary pathogenic mechanisms in XLMTM and CNM – Dr Susan Treves, Basel University Hospital, Basel and Dr Heinz Jungbluth, King’s College London – £116,664 over 3 years
- Pre-clinical gene replacement therapy for X-Linked myotubular myopathy – Dr Anna Buj Bello, Genethon, Evry – £110,300 over 2 years
- Reducing DNM2 as a novel therapeutic target for centronuclear myopathy – Dr Jocelyn Laporte, IGBMC, France – £132,000 over 3 years
- PI3 Kinase Inhibition as a Novel Treatment Strategy for MTM –Dr James, Dowling, Hospital for Sick Children, Toronto, Canada – £102,500 over 2 years
- Myotubular and Centronuclear Myopathy Patient Registry curation –TREAT-NMD team based at the John Walton Muscular Dystrophy Research Centre at Newcastle University – £40,744 over 2 years
In particular we would like to encourage the application of new technologies to research into myotubular myopathy, which may involve collaboration between different medical disciplines and / or different research institutions. We are also willing to consider applications which involve joint funding with other organisations.
Please see our Research Programme & Grants Information Page to read more and download an application form.